The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5

被引:60
作者
Zhang, Huan-Tian [1 ,2 ,3 ,4 ]
Zeng, Ling-Fei [3 ,4 ,5 ]
He, Qing-Yu [6 ]
Tao, W. Andy [3 ,4 ,5 ]
Zha, Zhen-Gang [1 ,2 ]
Hu, Chang-Deng [1 ,2 ,3 ,4 ]
机构
[1] Jinan Univ, Inst Orthoped Dis, Affiliated Hosp 1, Guangzhou 510630, Guangdong, Peoples R China
[2] Jinan Univ, Dept Orthoped, Affiliated Hosp 1, Guangzhou 510630, Guangdong, Peoples R China
[3] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA
[4] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA
[5] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA
[6] Jinan Univ, Key Lab Funct Prot Res, Guangdong Higher Educ Inst, Coll Life Sci & Technol, Guangzhou 510632, Guangdong, Peoples R China
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 2016年 / 1863卷 / 02期
关键词
CHIP; E3 ubiquitin ligase; PRMT5; Ubiquitination; Chaperone; Prostate cancer; ARGININE METHYLTRANSFERASE 5; PHASE-II TRIAL; TUMOR-SUPPRESSOR; NEUROENDOCRINE DIFFERENTIATION; PROTEIN-DEGRADATION; BREAST-CANCER; CELL-GROWTH; CHAPERONE; METHYLATION; EXPRESSION;
D O I
10.1016/j.bbamcr.2015.12.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein arginine methyltransferase 5 (PRMT5) is an important member of the protein arginine methyltransferase family that regulates many cellular processes through epigenetic control of target gene expression. Because of its overexpression in a number of human cancers and its essential role in cell proliferation, transformation, and cell cycle progression, PRMT5 has been recently proposed to function as an oncoprotein in cancer cells. However, how its expression is regulated in cancer cells remains largely unknown. We have previously demonstrated that the transcription of PRMT5 can be negatively regulated by the PKC/c-Fos signaling pathway through modulating the transcription factor NF-Y in prostate cancer cells. In the present study, we demonstrated that PRMT5 undergoes polyubiquitination, possibly through multiple lysine residues. We also identified carboxyl terminus of heat shock cognate 70-interacting protein (CHIP), an important chaperone-dependent E3 ubiquitin ligase that couples protein folding/refolding to protein degradation, as an interacting protein of PRMT5 via mass spectrometry. Their interaction was further verified by co-immuoprecipitation, GST pull-down, and bimolecular fluorescence complementation (BiFC) assay. In addition, we provided evidence that the CHIP/chaperone system is essential for the negative regulation of PRMT5 expression via K48-linked ubiquitin-dependent proteasomal degradation. Given that down-regulation of CHIP and overexpression of PRMT5 have been observed in several human cancers, our finding suggests that down-regulation of CHIP may be one of the mechanisms underlying PRMT5 overexpression in these cancers. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:335 / 346
页数:12
相关论文
共 62 条
[41]   DOG 1.0: illustrator of protein domain structures [J].
Ren, Jian ;
Wen, Longping ;
Gao, Xinjiao ;
Jin, Changjiang ;
Xue, Yu ;
Yao, Xuebiao .
CELL RESEARCH, 2009, 19 (02) :271-273
[42]   Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells [J].
Sarkar, S. ;
Brautigan, D. L. ;
Parsons, S. J. ;
Larner, J. M. .
ONCOGENE, 2014, 33 (01) :26-33
[43]   CHIP functions an E3 ubiquitin ligase of Runx1 [J].
Shang, Yu ;
Zhao, Xinghui ;
Xu, Xialian ;
Xin, Hong ;
Li, Xueni ;
Zhai, Yonggong ;
He, Dacheng ;
Jia, Baoqing ;
Chen, Wei ;
Chang, Zhijie .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 386 (01) :242-246
[44]   Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues [J].
Sharp, Swee Y. ;
Prodromou, Chrisostomos ;
Boxall, Kathy ;
Powers, Marissa V. ;
Holmes, Joanna L. ;
Box, Gary ;
Matthews, Thomas P. ;
Cheung, Kwai-Ming J. ;
Kalusa, Andrew ;
Janmes, Karen ;
Hayes, Angela ;
Hardcastle, Anthea ;
Dymock, Brian ;
Brough, Paul A. ;
Barril, Xavier ;
Cansfield, Julie E. ;
Wright, Lisa ;
Surgenor, Allan ;
Foloppe, Nicolas ;
Hubbard, Roderick E. ;
Aherne, Wynne ;
Pearl, Laurence ;
Jones, Keith ;
McDonald, Edward ;
Raynaud, Florence ;
Eccles, Sue ;
Drysdale, Martin ;
Workman, Paul .
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (04) :1198-1211
[45]   The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond [J].
Stopa, Nicole ;
Krebs, Jocelyn E. ;
Shechter, David .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2015, 72 (11) :2041-2059
[46]  
Suarez CD, 2014, AM J CANCER RES, V4, P850
[47]   Targeting the dynamic HSP90 complex in cancer [J].
Trepel, Jane ;
Mollapour, Mehdi ;
Giaccone, Giuseppe ;
Neckers, Len .
NATURE REVIEWS CANCER, 2010, 10 (08) :537-549
[48]   CHIP chaperones wild type p53 tumor suppressor protein [J].
Tripathi, Veenu ;
Ali, Amjad ;
Bhat, Rajiv ;
Pati, Uttam .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (39) :28441-28454
[49]   Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells [J].
Wang, Li ;
Pal, Sharmistha ;
Sif, Said .
MOLECULAR AND CELLULAR BIOLOGY, 2008, 28 (20) :6262-6277
[50]   Quantitative phosphoproteomics identifies SnRK2 protein kinase substrates and reveals the effectors of abscisic acid action [J].
Wang, Pengcheng ;
Xue, Liang ;
Batelli, Giorgia ;
Lee, Shinyoung ;
Hou, Yueh-Ju ;
Van Oosten, Michael J. ;
Zhang, Huiming ;
Tao, W. Andy ;
Zhu, Jian-Kang .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (27) :11205-11210